| Catalog Number |
ACMA00065257 |
| Description |
Fezolinetant is intended for Pharmaceuticals applications and is an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Fezolinetant is a neurokinin 3 (NK3) receptor antagonist approved by the FDA. All information about [2H4]-Fezolinetant is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Synonyms |
Fezolinetant-D4 |
| Molecular Weight |
362.42 |
| Molecular Formula |
C16H15FN6OS |
| Purity |
≥98% |
| Isotopic Enrichment |
98% 2H |
| Stability |
≥1 year |
| Unlabeled CAS |
1629229-37-3 |
Please kindly note that our products and services are for research use only.
